Xeris Biopharma Holdings Inc (XERS)
3.09
+0.05
(+1.64%)
USD |
NASDAQ |
Nov 22, 16:00
3.085
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Revenue (TTM): 187.36M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 187.36M |
| June 30, 2024 | 181.41M |
| March 31, 2024 | 171.36M |
| December 31, 2023 | 163.91M |
| September 30, 2023 | 152.67M |
| June 30, 2023 | 134.07M |
| March 31, 2023 | 121.37M |
| December 31, 2022 | 110.25M |
| September 30, 2022 | 98.53M |
| June 30, 2022 | 79.87M |
| March 31, 2022 | 63.47M |
| December 31, 2021 | 49.59M |
| September 30, 2021 | 35.53M |
| June 30, 2021 | 33.87M |
| Date | Value |
|---|---|
| March 31, 2021 | 27.00M |
| December 31, 2020 | 20.48M |
| September 30, 2020 | 14.97M |
| June 30, 2020 | 5.88M |
| March 31, 2020 | 4.15M |
| December 31, 2019 | 2.722M |
| September 30, 2019 | 1.617M |
| June 30, 2019 | 1.886M |
| March 31, 2019 | 2.408M |
| December 31, 2018 | 2.423M |
| September 30, 2018 | 2.131M |
| June 30, 2018 | 1.719M |
| March 31, 2018 | 1.465M |
| December 31, 2017 | 1.556M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
2.722M
Minimum
Dec 2019
187.36M
Maximum
Sep 2024
82.92M
Average
71.67M
Median
Revenue (TTM) Benchmarks
| Zevra Therapeutics Inc | 24.49M |
| NovaBay Pharmaceuticals Inc | 13.84M |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |